Personalized Stem Cells Gains Approval for Trial of Stem Cell OA Treatment

Personalized Stem Cells (PSC), a human adipose-derived stem cell company, received FDA approval for an Investigational New Drug (IND) application for use of a person’s own stem cells to treat osteoarthritis. The first clinical trial will investigate use in the treatment of knee OA.

Future trials are planned for other orthopedic...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us